PPARα Inhibits TGF-β–Induced β 5 Integrin Transcription in Vascular Smooth Muscle Cells by Interacting With Smad4
- 29 November 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 91 (11) , e35-44
- https://doi.org/10.1161/01.res.0000046017.96083.34
Abstract
Integrins play an important role in vascular smooth muscle cell (VSMC) migration, a crucial event in the development of restenosis and atherosclerosis. Transforming growth factor-β (TGF-β) is highly expressed in restenotic and atherosclerotic lesions, and known to induce integrin expression. Peroxisome proliferator-activated receptor α (PPARα), a member of the nuclear receptor superfamily, regulates gene expression in a variety of vascular cells. We investigated the effects of PPARα ligands on TGF-β–induced β 3 and β 5 integrin expression and potential interaction between PPARα and TGF-β signaling. PPARα ligands WY-14643 (100 μmol/L) and 5,8,11,14-eicosatetranoic acid (ETYA, 50 μmol/L) inhibited TGF-β–induced β 5 integrin protein expression by 72±6.8% and 73±7.1%, respectively (both P 3 integrin expression was not affected by PPARα ligands. Both PPARα ligands also suppressed TGF-β–induced β 5 integrin mRNA levels. PPARα ligands inhibited TGF-β–inducible transcription of β 5 integrin by an interaction with a TGF-β response element between nucleotides −63 and −44, which contains a Sp1/Sp3 transcription factor binding site. Nuclear complexes binding to the TGF-β response region contained Sp1/Sp3 and TGF-β–regulated Smad 2, 3, and 4 transcription factors. TGF-β–stimulated Sp1/Smad4 nuclear complex formation was inhibited by WY-14643 and ETYA with a parallel induction of PPARα/Smad4 interactions. However, in vitro pull-down experiments failed to demonstrate direct binding between PPARα/Smad4. Both PPARα ligands blocked PDGF-directed migration of TGF-β–pretreated VSMCs, a process mediated, in part, by β 5 integrins. The present study demonstrates that PPARα activators inhibit TGF-β–induced β 5 integrin transcription in VSMCs through a novel indirect interaction between ligand-activated PPARα and the TGF-β–regulated Smad4 transcription factors. The full text of this article is available at http://www.circresaha.org.Keywords
This publication has 32 references indexed in Scilit:
- Peroxisome Proliferator-activated Receptor γ Inhibits Transforming Growth Factor β-induced Connective Tissue Growth Factor Expression in Human Aortic Smooth Muscle Cells by Interfering with Smad3Journal of Biological Chemistry, 2001
- Peroxisome Proliferator-activated Receptor γ Ligands Inhibit Retinoblastoma Phosphorylation and G1 → S Transition in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 2000
- Tumor Necrosis Factor α Inhibits Insulin-induced Mitogenic Signaling in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 2000
- ?v?3, ?v?5, and osteopontin are coordinately upregulated at early time points in a rabbit model of neointima formationJournal of Cellular Biochemistry, 1999
- Cloning of the Murine β5 Integrin Subunit PromoterPublished by Elsevier ,1999
- The extracellular matrix as a cell cycle control element in atherosclerosis and restenosis.Journal of Clinical Investigation, 1996
- The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro.Journal of Clinical Investigation, 1995
- Stimulation of migration of human aortic smooth muscle cells by vitronectin: implications for atherosclerosisCardiovascular Research, 1994
- Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.Journal of Clinical Investigation, 1994
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992